Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2005
05/19/2005US20050106664 Genetically engineered methylotrophic yeast for use as bioreactor in production of glycoproteins with mammalian-like glycosylation
05/19/2005US20050106663 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide
05/19/2005US20050106660 Subjecting apoliprotein to mutagenesis at sequence positions 34 to 38 and other positions and muteins of aliproteins
05/19/2005US20050106659 Membrane protein for use as tool in detection of modulators for diagnosis, prevention and treatment of neurological and/or psychiatric diseases
05/19/2005US20050106658 Remodeling and glycoconjugation of peptides
05/19/2005US20050106654 Animal model lacking histone deacetylase (HDAC) for use as diagnostic tool in detection, diagnosis and prevention of cardiac hypertrophy
05/19/2005US20050106647 Antibodies with increased affinities for anthrax antigens
05/19/2005US20050106643 Using intracellular protein which are expressed in a hormonally dependent manner as diagnostic indicator of cell proliferative disorders of breast and prostate
05/19/2005US20050106639 Method for quantification of AKT protein expression
05/19/2005US20050106638 Immunoglobulin for use in diagnosis, prevention and treatment of fibrosis and scarring; antiscarring agents
05/19/2005US20050106636 Method and kit for detecting membrane protein-protein interactions
05/19/2005US20050106628 MEGSIN protein
05/19/2005US20050106622 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/19/2005US20050106614 Reagents and methods useful for detecting diseases of the prostate
05/19/2005US20050106611 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
05/19/2005US20050106610 Kits containing modified amplification oligonucleotides
05/19/2005US20050106609 Method of detecting a DNA sequence, a DNA sequence, a method of making a DNA construct and the use thereof
05/19/2005US20050106604 Using two-phase isolation to separate and recover biopolymers in solution. electrophoretic separation
05/19/2005US20050106601 Transgenic mouse whose somatic and germ cells express an Fkhsf transgene and mutants; immunomodulators
05/19/2005US20050106600 Immunoglobulin for use in diagnosis, prevention, and treatment of tumor progression in cells; immunodiagnostic and therapeutics
05/19/2005US20050106599 Nucleotide sequences coding secretfed protein for use as tools in generating antibodies for use in forensics, gene therapeutics and diagnostics and chromosome mapping
05/19/2005US20050106598 Enhanced cellular uptake
05/19/2005US20050106597 Nucleotide sequences coding bacterial polypeptides for use in generating antibodies to prevent and treat staphylococcal infection
05/19/2005US20050106595 Expressed sequence tags and encoded human proteins
05/19/2005US20050106590 Preparing preferential nucleotide sequences using overlapping regions and frameshift vectors; gene expression analysis
05/19/2005US20050106588 O-methyltransferases of tetrahydrobenzylisoquinoline alkaloid biosynthesis in Papaver somniferum
05/19/2005US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease
05/19/2005US20050106567 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders
05/19/2005US20050106559 Viral vector
05/19/2005US20050106558 Generating viral expression vector comprising parvoviral structural genes for use as gene transfer and expression tool; treatment and prevention of infections, cell proliferative and autoimmune disorders
05/19/2005US20050106222 Genetic engineering; gene expression; polypeptides
05/19/2005US20050106184 Genetic engineered mutants lipid
05/19/2005US20050106176 Vector reproduction using Dna polymerase; linking to chromosome; encoded as foreign gene; genetic engineering
05/19/2005US20050106164 Recombinant expression of heterologous nucleic acids in protozoa
05/19/2005US20050106162 Immunisation against chlamydia trachomatis
05/19/2005US20050106154 GASP1: a follistatin domain containing protein
05/19/2005US20050106145 Anti-human tenascin monoclonal antibody
05/19/2005US20050106143 Collapsin response mediator protein; measurement of gene expression
05/19/2005US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof
05/19/2005US20050106134 Pregnancy-related enzyme activity
05/19/2005US20050106125 Nucleic acid gene expression; insertion of adeno-associated virus; inverted terminal repeat sequences ; anticancer agents
05/19/2005US20050106124 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
05/19/2005US20050106123 Using primers; heterogeneity genetic engineered adenovirus or poxviruse vectors
05/19/2005US20050106108 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
05/19/2005US20050106099 Fusion proteins
05/19/2005US20050104698 Electromagnetic device, high-voltage generating device, and method for making the electromagnetic device
05/19/2005US20050102762 An endoglucanase derived from Zygomycetes that may have a cellulose binding domain deleted; treating a cellulose fabric with the cellulase preparation to improve a property; deinking waste paper; improving freeness of paper pulp
05/19/2005DE19905501B4 Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels A method of producing a recombinant adeno-associated virus, as well as suitable means to this end use for the preparation of a medicament
05/19/2005DE10346627A1 Single-chain-Antikörper gegen den 37 kDa/67 kDa Lamininrezeptor als Werkzeuge zur Diagnose und Therapie von Prionerkrankungen und Krebs, deren Herstellung und Verwendung Single-chain antibody against the 37 kDa / 67 kDa laminin as tools for diagnosis and therapy of prion diseases and cancer, their preparation and use
05/19/2005DE10164819A1 Verfahren zur Identifizierung von Zielepitopen der T-Zell-vermittelten Immunantwort und zum Nachweis Epitop-spezifischer T-Zellen A method for identifying target epitopes of the T-cell mediated immune response and for the detection of epitope-specific T-cells
05/19/2005DE10154291B4 Verfahren zum Nachweis von Nukleinsäuren in Form eines Trockenschnelltestes A method for detecting nucleic acids in the form of a dry rapid test
05/19/2005DE10148828B4 Modulation der Expression STAT-1-abhängiger Gene Modulating the expression of STAT-1-dependent genes
05/19/2005CA2566823A1 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
05/19/2005CA2548538A1 Compositions and methods of use for a fibroblast growth factor
05/19/2005CA2546083A1 Novel brevibacillus choshinensis and method for producing protein using the microorganism as host
05/19/2005CA2545171A1 Screening method with the use of tbk1 knockout mouse
05/19/2005CA2545166A1 Humanized anti-cd47 antibody
05/19/2005CA2545160A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
05/19/2005CA2544841A1 Pola dna polymerases capable of abasic site bypass
05/19/2005CA2544821A1 Simian orl1 gene and method of assessing compound
05/19/2005CA2544764A1 Protein binding miniature proteins
05/19/2005CA2544214A1 Hla-dr-binding antigen peptide derived from wt1
05/19/2005CA2544207A1 Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms
05/19/2005CA2543866A1 Protozoan strains of reduced virulence and use thereof
05/19/2005CA2543719A1 Methods and compositions for modulating apoptosis
05/19/2005CA2543442A1 High temperature and alkaline stable catalase
05/19/2005CA2543030A1 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina)
05/19/2005CA2543029A1 Rna interference mediated inhibition of gpra and aaa1 gene expression using short nucleic acid (sina)
05/19/2005CA2543013A1 Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina)
05/19/2005CA2542835A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
05/19/2005CA2542527A1 Rna interferance mediated inhibition of cholinergic muscarinic receptor (chrm3) gene expression using short interfering nucleic acid /sina)
05/19/2005CA2541643A1 Rna interference mediated inhibition of hairless (hr) gene expression using short interfering nucleic acid (sina)
05/19/2005CA2535147A1 Improved glucose dehydrogenase polypeptides and related polynucleotides
05/19/2005CA2528574A1 Genes encoding carotenoid compounds
05/18/2005EP1531333A1 Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism
05/18/2005EP1531184A2 Genetic testing kit and method for bladder cancer
05/18/2005EP1531181A2 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes
05/18/2005EP1531180A1 Method of diagnosing risk of myocardial infarction
05/18/2005EP1531161A2 Human epidermal proteins HEPI-1 to HEPI-6
05/18/2005EP1530973A2 Methods for inducing T cell tolerance to a tissue or organ graft
05/18/2005EP1530725A1 Materials and methods for inductions of immune tolerance
05/18/2005EP1530724A2 Diagnosis and prevention of cancer cell invasion
05/18/2005EP1530648A1 Methods and device for decarbonising a steel melt
05/18/2005EP1530645A2 Method of identifying genes involved in cell growth regulation
05/18/2005EP1530644A2 Probes for detecting tumor cells
05/18/2005EP1530643A2 Chimeric protein
05/18/2005EP1530641A2 Dna expression construct for multiple gene expression
05/18/2005EP1530640A2 Method for identifying substances having a herbicide action
05/18/2005EP1530639A2 Gene and polypeptide sequences
05/18/2005EP1530638A2 T-cell epitopes in staphylococcal enterotoxin b
05/18/2005EP1530637A2 Subtilisin carlsberg proteins with reduced immunogenicity
05/18/2005EP1530636A1 Treatment of melanoma by reduction in clusterin levels
05/18/2005EP1530635A2 Ghrelin binding nucleic acids
05/18/2005EP1530634A2 Modified shine-dalgarno sequences and methods of use thereof
05/18/2005EP1530633A2 Isolation and cloning of dna from uncultivated organisms
05/18/2005EP1530632A2 Growth factor which acts through erb b-4 rtk
05/18/2005EP1530631A2 Multiply-substituted protease variants
05/18/2005EP1530630A2 Novel lipases and uses thereof
05/18/2005EP1530592A1 Chimeric mhc protein and oligomer thereof
05/18/2005EP1530590A2 Triggering receptors expressed on myeloid cells (trem)-4 and -5 and uses thereof
1 ... 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 ... 4023